Abacavir and lamivudine combination

Author： Somboonwit Charurut   Kurtyka Don   Paula Velez Ana  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.5, Iss.12, 2009-12, pp. : 1599-1606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lamivudine/Zidovudine/Abacavir: Triple Combination Tablet

By Ibbotson T.   Perry C.M.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1089-1098

Adis International

Access to resources Recommend Favorite

Abacavir/lamivudine fixed-dose combination tablet for the treatment of HIV-1 infection

By Taylor Clare L   Wilkins Edmund GL  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Fixed-dose combination of abacavir, lamivudine and zidovudine for HIV therapy

By Milinkovic Ana   Mallolas Josep  

Future Virology, Vol. 2, Iss. 1, 2007-01 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

The once-daily lamivudine plus abacavir fixed combination is noninferior to the twice daily regimen of the individual components

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy

By Castillo Steve A.   Hernandez Jaime E.   Brothers Cindy H.  

Drug Safety, Vol. 29, Iss. 9, 2006-01 ,pp. : 811-826

Adis International

Access to resources Recommend Favorite